Moreover, miR-20a is reported to promote the multidrug resistance (MDR) of GC cells by activating the epidermal growth factor receptor-mediated PI3K/AKT and MAPK/ERK signaling pathways by targeting LRIG1 (126). This evidence concerns the gene AKT1 and gastric cancer.